Detalhe da pesquisa
1.
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.
Blood
; 137(6): 733-742, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150928
2.
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017.
Emerg Infect Dis
; 27(7): 1876-1885, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152955
3.
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.
Am J Hematol
; 96(3): 302-311, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306213
4.
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
Transfus Apher Sci
; 58(6): 102665, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740165
5.
Intensive rituximab regimen in immune-mediated thrombotic thrombocytopenic purpura can circumvent unresponsiveness to standard rituximab treatment.
Br J Haematol
; 192(1): e21-e25, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216951
6.
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.
Haematologica
; 101(8): 976-84, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27175027
7.
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.
Transfusion
; 54(2): 389-97, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23711330
8.
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Crit Care Med
; 40(1): 104-11, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21926591
9.
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Haematologica
; 97(8): 1181-6, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22580997
10.
Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Transfusion
; 52(11): 2436-44, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22404639
11.
Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura.
Hemasphere
; 4(4): e462, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885148
12.
Cancer awareness in atypical thrombotic microangiopathies.
Oncologist
; 14(8): 769-79, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19684072
13.
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.
Medicine (Baltimore)
; 83(4): 233-244, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15232311
14.
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.
PLoS One
; 5(4): e10208, 2010 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20436664